Literature DB >> 15086379

Drugs, sun and T cells in lupus.

G C Tsokos.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15086379      PMCID： PMC1809012          DOI： 10.1111/j.1365-2249.2004.02455.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  30 in total

1.  Increased CCR4 expression in active systemic lupus erythematosus.

Authors:  K Hase; K Tani; T Shimizu; Y Ohmoto; K Matsushima; S Sone
Journal:  J Leukoc Biol       Date:  2001-11       Impact factor: 4.962

2.  Deficiency in beta(2)-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRL-Fas(lpr) nice: an example of disease regulation at the organ level.

Authors:  O T Chan; V Paliwal; J M McNiff; S H Park; A Bendelac; M J Shlomchik
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

3.  NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.

Authors:  S T Waters; S M Fu; F Gaskin; U S Deshmukh; S S Sung; C C Kannapell; K S Tung; S B McEwen; M McDuffie
Journal:  Clin Immunol       Date:  2001-09       Impact factor: 3.969

4.  Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the gamma delta T-cell antigen receptor.

Authors:  S Rajagopalan; T Zordan; G C Tsokos; S K Datta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.

Authors:  T Yoshimasu; T Nishide; N Seo; A Hiroi; T Ohtani; K Uede; F Furukawa
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

6.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis.

Authors:  T Takeuchi; K Amano; H Sekine; J Koide; T Abe
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.

Authors:  Dimitrios T Boumpas; Richard Furie; Susan Manzi; Gabor G Illei; Daniel J Wallace; James E Balow; Akshay Vaishnaw
Journal:  Arthritis Rheum       Date:  2003-03

9.  T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.

Authors:  S Shivakumar; G C Tsokos; S K Datta
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

10.  The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice.

Authors:  T J Santoro; J P Portanova; B L Kotzin
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.